Octapharma AG: European Commission Adopts European Medicines Agency's (EMA) Recommendation to Lift the Suspension of the Marketing Authorization of octagam(R) and octagam(R)10%

Published: May 31, 2011

On 30 May 2011 The European Commission adopted the EMA's recommendation of 14 April 2011 revised on May 12, 2011 to lift the suspension of the marketing authorization of octagam® and octagam®10%, thus allowing both products back on the European markets.

Back to news